| Immune Response to a Delayed Second Dose of Oral Cholera Vaccine (NCT05453253) | Epicentre | 2022-07-20 |
| A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). (NCT05507229) | Bharat Biotech International Limited | 2022-02-22 |
| Preventative Intervention for Cholera for 7 Days (NCT05166850) | Johns Hopkins Bloomberg School of Public Health | 2021-12-22 |
| Single Dose Azithromycin to Prevent Cholera in Children (NCT04326478) | Massachusetts General Hospital | 2021-10-31 |
| Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ (NCT04760236) | International Vaccine Institute | 2021-10-06 |
| Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence (NCT05829772) | Epicentre | 2021-09-20 |
| Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance (NCT04853186) | Epicentre | 2021-05-11 |
| Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change (NCT04816552) | Johns Hopkins Bloomberg School of Public Health | 2021-03-22 |
| Cholera Anti-Secretory Treatment Trial (NCT04150250) | PATH | 2019-11-04 |
| Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine (NCT03373669) | Johns Hopkins Bloomberg School of Public Health | 2017-11-16 |
| Immunogenicity of Cholera Vaccine in Children With IBD (NCT03998449) | Medical University of Warsaw | 2017-08-30 |
| Immunologic Responses to a Live Attenuated Oral Cholera Vaccine (NCT03251495) | Emory University | 2017-08-29 |
| Cholera-Hospital-Based-Intervention-for-7-days (NCT04008134) | Johns Hopkins Bloomberg School of Public Health | 2016-12-04 |
| Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo (NCT02928341) | London School of Hygiene and Tropical Medicine | 2016-10-01 |
| Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine (NCT02823899) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2016-07-01 |
| Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine (NCT02742558) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2016-04-01 |
| Safety and Immunogenicity of a New Formulation of Euvichol® (NCT02502331) | International Vaccine Institute | 2016-03-01 |
| Cholera Vaccine Investment Strategy in Bangladesh (NCT02727855) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2016-01-01 |
| Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants (NCT00548054) | International Vaccine Institute | 2015-12-01 |
| Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi (NCT02499172) | Johns Hopkins Bloomberg School of Public Health | 2015-06-01 |
| A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic (NCT02434822) | Sanofi Pasteur, a Sanofi Company | 2015-04-01 |
| PXVX0200 (CVD103-HgR) vs Shanchol in Mali (NCT02145377) | University of Maryland, Baltimore | 2014-07-01 |
| A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults (NCT02094586) | Bavarian Nordic | 2014-05-01 |
| A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults (NCT02100631) | Bavarian Nordic | 2014-05-01 |
| A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines (NCT01949675) | Sanofi Pasteur, a Sanofi Company | 2014-03-01 |
| Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera (NCT01895855) | Bavarian Nordic | 2013-09-01 |
| PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera (NCT01823939) | PATH | 2013-05-01 |
| Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine (NCT01508507) | International Vaccine Institute | 2013-03-01 |
| Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh (NCT02027207) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2012-12-09 |
| Evaluation of a Boosting Regimen With Oral Cholera Vaccine (NCT01579448) | Sachin Desai | 2012-12-01 |
| Bridging Study for Killed Oral Cholera Vaccine in Ethiopia (NCT01524640) | International Vaccine Institute | 2012-12-01 |
| Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts (NCT02864433) | Brigham and Women's Hospital | 2012-10-01 |
| Oral Cholera Vaccine Delivery in Rural Bangladesh (NCT01811771) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2012-08-01 |
| Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 (NCT01585181) | Bavarian Nordic | 2012-04-01 |
| Pilot Introduction of Oral Cholera Vaccine in Orissa, India (NCT01365442) | International Vaccine Institute | 2011-05-01 |
| Study of Alternative Vaccination Schedule of Oral Cholera Vaccine (NCT01233362) | International Vaccine Institute | 2010-12-01 |
| Introduction of Cholera Vaccine in Bangladesh (NCT01339845) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2009-09-01 |
| Mass Oral Cholera Vaccination in Zanzibar (NCT00709410) | International Vaccine Institute | 2009-01-01 |
| Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants (NCT00624975) | International Vaccine Institute | 2008-11-01 |
| Protective Immunity to Human Cholera in Bangladesh (NCT00349999) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-01 |
| Studies of Immune Responses to Orally Administered Vaccines in Developing Country (NCT01019083) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2008-02-01 |
| Ciprofloxacin Multiple Dose for Adult Cholera (NCT00741052) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2007-07-01 |
| Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine (NCT00419133) | International Vaccine Institute | 2007-06-01 |
| Immunity to Human Cholera in Bangladesh (NCT00401934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-12-11 |
| Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata (NCT00289224) | International Vaccine Institute | 2006-07-01 |
| Effect of Probiotic on Immunogenicity of Oral Cholera Vaccine (NCT00464867) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2006-01-01 |
| Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata (NCT00119197) | International Vaccine Institute | 2005-08-01 |
| Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine (NCT00128011) | International Vaccine Institute | 2005-05-01 |
| Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in Adults (NCT00672308) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2003-05-01 |
| Single Dose Azithromycin in the Treatment of Adult Cholera (NCT00229944) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2002-12-01 |
| Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial (NCT00142272) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2001-05-01 |
| Zinc Supplementation in Cholera Patients (NCT00226616) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2000-11-01 |